Clinical Cardiac Electrophysiology – An Overview

  • Senthil Thenappan
  • Jaffar Ali Raza
  • R. Wayne Kreeger
  • Assad Movahed

Abstract

Clinical cardiac electrophysiology is a subspecialty of cardiology dealing with the evaluation and management of patients with complex rhythm or conduction abnormalities. In the last four decades, clinical cardiac electrophysiology has evolved into an established discipline credited with improving and saving hundreds of thousands of lives. We briefly review the basic electrophysiologic principles, anatomy of the electric system of the heart, mechanism of arrhythmias, genetical predisposition to arrhythmias, types of arrhythmias, diagnostic electrophysiologic studies, and pharmacologic and device therapies available for the treatment of different types of arrhythmias.

Keywords

Cardiomyopathy Cardiol Verapamil Amiodarone Myopathy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hoffman BF (1999) Cardiac arrhythmias: what do we need to know about basic mechanisms? J Cardiovasc Electrophysiol 10(3):414–416.PubMedCrossRefGoogle Scholar
  2. 2.
    Satoh T, Zipes DP (1998) Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes? J Cardiovasc Electrophysiol 9(9):970–975.PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson ME (2002) Calmodulin and the philosopher’s stone: Changing Ca2+ into arrhythmias. J Cardiovasc Electrophysiol 13(2):195–197.PubMedCrossRefGoogle Scholar
  4. 4.
    Coumel P, Leclercq JF, Lucet V (1985) Possible mechanisms of the arrhythmias in the long QT syndrome. Eur Heart J 6Suppl D: 115–129.PubMedGoogle Scholar
  5. 5.
    El-Sherif N (2001) Mechanism of ventricular arrhythmias in the long QT syndrome: On hermeneutics. J Cardiovasc Electrophysiol 12:973–976.PubMedCrossRefGoogle Scholar
  6. 6.
    El-Sherif N, Caref EB, Yin H, Restivo M (1996) The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Tridimensional mapping of activation and recovery patterns. Circ Res 79(3):474–492.PubMedGoogle Scholar
  7. 7.
    Zipes DP (2003) Mechanisms of clinical arrhythmias. J Cardiovasc Electrophysiol 14(8):902–9012.PubMedCrossRefGoogle Scholar
  8. 8.
    Zipes DP, DiMarco JP, Gillette PC et al. (1995) Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 26:555–573.PubMedCrossRefGoogle Scholar
  9. 9.
    Tracy et al. (2000) Clinical competence statement on invasive electrophysiology. J Am Coll Cardiol 36: 1725–1736.PubMedCrossRefGoogle Scholar
  10. 10.
    Chiang CE (2004) Congenital and acquired long QT syndrome. Current concepts and management. Cardiol Rev 12(4):222–234.PubMedCrossRefGoogle Scholar
  11. 11.
    Roden DM, Viswanathan PC (2005) Genetics of acquired long QT syndrome. J Clin Invest 115(8):2025–2032.PubMedCrossRefGoogle Scholar
  12. 12.
    Moss AJ, Kass RS (2005) Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 115(8):2018–2024.PubMedCrossRefGoogle Scholar
  13. 13.
    Alings M, Wilde A (1999) Brugada syndrome: clinical data and suggested pathophysiological mechanism. Circulation 99:666–673.PubMedGoogle Scholar
  14. 14.
    Gussak I, Antzelevitch C, Bjerregaard P et al. (1999) The Brugada syndrome: clinical, electrophysiological and genetic aspects. J Am Coll Cardiol 33:5–15.PubMedCrossRefGoogle Scholar
  15. 15.
    Chen Q, Kirsch GE, Zhang D et al. (1998) Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 19:293–296.Google Scholar
  16. 16.
    Kies P, Bootsma M, Bax J, Schalij MJ, van der Wall EE (2006) Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Screening, diagnosis, and treatment. Heart Rhythm 3(2):225–234.PubMedCrossRefGoogle Scholar
  17. 17.
    Nishimura RA, Holmes DR Jr (2004) Hypertrophic obstructive cardiomyopathy. N Engl J Med 350:1320–1327.PubMedCrossRefGoogle Scholar
  18. 18.
    The Cardiac Arrhythmia Suppression Trial (CAST) (1989) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406–412.Google Scholar
  19. 19.
    Chaudhry GM, Haffajee CI (2000) Anti-arrhythmic agents and proarrhythmia [review]. Crit Care Med 28:N158–N164. PubMedCrossRefGoogle Scholar
  20. 20.
    Zipes DP, Wellens HJJ (1998) Sudden cardiac death. Circulation 98:2334–2351.PubMedGoogle Scholar
  21. 21.
    Huikuri HV, Castellanos A, Myerburg RJ (2001) Sudden death due to cardiac arrhythmias. N Engl J Med 345:1473–1482.PubMedCrossRefGoogle Scholar
  22. 22.
    Mirowski M, Mower MM (1973) Transvenous automatic defibrillator as an approach to prevention of sudden death from ventricular fibrillation. Heart Lung 2:867–869.PubMedGoogle Scholar
  23. 23.
    Mirowski M, Mower MM, Langer A, Heilman MS, Schreibmen J (1978) A chronically implanted system for automatic defibrillation in active conscious dogs: experimental model for treatment of sudden death from ventricular fibrillation. Circulation 58:90–94.PubMedGoogle Scholar
  24. 24.
    DiMarco JP (2003) Implantable cardioverter-defibrillators. N Engl J Med 349:1836–1847.PubMedCrossRefGoogle Scholar
  25. 25.
    Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT (1994) Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 23:1342–1355.PubMedGoogle Scholar
  26. 26.
    Moss AJ, Hall WJ, Cannom DS et al. (1996) Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–940.PubMedCrossRefGoogle Scholar
  27. 27.
    Moss AJ, Zareba W, Hall WJ et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883.PubMedCrossRefGoogle Scholar
  28. 28.
    Bardy GH, Lee KL, Mark DB et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237.PubMedCrossRefGoogle Scholar
  29. 29.
    Bigger JT Jr, Whang W, Rottman JN et al. (1999) Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 99:1416–1421.PubMedGoogle Scholar
  30. 30.
    Bänsch D, Antz M, Boczor S et al. (2002) Primary prevention of sudden death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105:1453–1458.PubMedCrossRefGoogle Scholar
  31. 31.
    The Anti-arrhythmic versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of anti-arrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–1583.CrossRefGoogle Scholar
  32. 32.
    Connolly SJ, Gent M, Roberts RS et al. (2000) Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297–1302.PubMedGoogle Scholar
  33. 33.
    Kuck KH, Cappato R, Siebels J, Ruppel R (2000) Randomized comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102:748–754.PubMedGoogle Scholar
  34. 34.
    Connolly SJ, Hallstrom AP, Cappato R et al. (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies. Eur Heart J 21:2071–2078.PubMedCrossRefGoogle Scholar
  35. 35.
    Gregoratos et al. (2002) ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices.Google Scholar
  36. 36.
    Morady F (1999) Radiofrequency ablation as treatment for cardiac arrhythmias. N Engl J Med 340: 534–544.PubMedCrossRefGoogle Scholar
  37. 37.
    Scheinman MM, Morady F, Hess DS, Gonzalez R (1982) Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. J Am Med Assoc 248:851–855.CrossRefGoogle Scholar
  38. 38.
    Morady F, Calkins H, Langberg JJ et al. (1993) A prospective randomized comparison of direct current and radiofrequency ablation of the atrioventricular junction. J Am Coll Cardiol 21:102–109.PubMedCrossRefGoogle Scholar
  39. 39.
    Olgin JE, Scheinman MM (1993) Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction. J Am Coll Cardiol 21:557–564.PubMedGoogle Scholar
  40. 40.
    Huang SK, Graham AR, Wharton K (1988) Radiofrequency catheter ablation of the left and right ventricles: anatomic and electrophysiologic observations. Pacing Clin Electrophysiol 11:449–459.PubMedCrossRefGoogle Scholar
  41. 41.
    Evans GTJ, Scheinman MM, Zipes DP et al. (1988) The Percutaneous Cardiac Mapping and Ablation Registry: final summary of results. Pacing Clin Electrophysiol 11:1621–1626.PubMedCrossRefGoogle Scholar
  42. 42.
    Scheinman MM (1995) NASPE survey on catheter ablation. Pacing Clin Electrophysiol 18:1474–1478.PubMedCrossRefGoogle Scholar
  43. 43.
    Hindricks G (1996) Incidence of complete atrioventricular block following attempted radiofrequency catheter modification of the atrioventricular node in 880 patients: results of the Multicenter European Radiofrequency Survey (MERFS): the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 17:82–88.PubMedGoogle Scholar
  44. 44.
    Kusumoto FM, Goldschlager N (1996) Cardiac pacing. N Engl J Med 334:89–97.PubMedCrossRefGoogle Scholar
  45. 45.
    Hayes DL, Furman S (2004) Cardiac pacing: how it started, where we are, where we are going. J Cardiovasc Electrophysiol 15(5):619–627.PubMedGoogle Scholar
  46. 46.
    Abraham WT, Hayes DL (2003) Cardiac resynchronization therapy for heart failure. Circulation 108(21):2596–2603.PubMedCrossRefGoogle Scholar
  47. 47.
    Abraham WT, Fisher WG, Smith AL et al. (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1902–1905.CrossRefGoogle Scholar
  48. 48.
    Auricchio A, Stellbrink C, Sack S (2002) Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39:2026–2033.PubMedCrossRefGoogle Scholar
  49. 49.
    Cazeau S, Leclercq C, Lavergne T et al. (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344: 873–880.PubMedCrossRefGoogle Scholar
  50. 50.
    Bristow MR, Feldman AM, Saxon LA (2000) Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail 6:276–285.PubMedCrossRefGoogle Scholar
  51. 51.
    Kühlkamp V (2002) Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 39:790–797.PubMedCrossRefGoogle Scholar
  52. 52.
    Lozano I, Bocchiardo M, Achtelik M et al. (2000) Impact of biventricular pacing on mortality in a randomized crossover study of patients with heart failure and ventricular arrhythmias. Pacing Clin Electrophysiol 23:1711–1712.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Senthil Thenappan
    • 1
  • Jaffar Ali Raza
    • 2
  • R. Wayne Kreeger
    • 1
  • Assad Movahed
    • 1
  1. 1.The Brody School of Medicine, Department of Medicine, Section of CardiologyEast Carolina UniversityGreenvilleUSA
  2. 2.Department of Interventional CardiologyLenox Hill Heart and Vascular InstituteNew YorkUSA

Personalised recommendations